Round Led by Ambit Health Ventures Positions Smartlens for Market Entry and Future Growth SUNNYVALE, Calif., Oct. 14, 2025 /PRNewswire/ -- Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, today announced the closing of...
Smartlens, Inc. Secures $5.2 Million Bridge Round to Advance FDA Clearance Process and Prepare for Commercial Launch of miLens
